Central Neurotoxicity of Immunomodulatory Drugs in Multiple Myeloma

Immunomodulatory drugs (IMiDs) currently used in the treatment of multiple myeloma, are thalidomide, lenalidomide and pomalidomide. One of the most common side effects of thalidomide is neurotoxicity, predominantly in the form of peripheral neuropathy. We report 6 cases of significant central neurot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hematol Rep
Autores principales: Patel, Urmeel H., Mir, Muhammad A., Sivik, Jeffrey K., Raheja, Divisha, Pandey, Manoj K., Talamo, Giampaolo
Formato: Artigo
Lenguaje:Inglês
Publicado: PAGEPress Publications, Pavia, Italy 2015
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378207/
https://ncbi.nlm.nih.gov/pubmed/25852850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5704
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares